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Abstract 
AIM: To evaluate the relationship between osteopontin and diabetes complication in type 1 diabetic patient. 
PATIENTS AND METHODS: Seventy types 1 diabetic and 60 healthy volunteers were studied. Full history, 
examination, laboratory tests of glycosylated haemoglobin (HbA1c), serum lipids {cholesterol, triglyceride (Tg), 
high-density lipoprotein-cholesterol (HDL-c), low-density lipoprotein – cholesterol (LDL-c)}, oxidised low-density 
lipoprotein (OxLDL), Osteopontin and urinary microalbuminuria (albumin/creatinine ratio) were done. Image study 
in the form of a carotid intimal medial thickness (cIMT) and aortic intimal medial thickness (aIMT), renal doppler 
for resistivity index was also done for all participant included in the study. 
RESULTS: Urinary albumin/creatinine ratio, lipid profile, osteopontin, cIMT and aIMT were higher in people with 
diabetes. Osteopontin was higher in people with diabetes with positive microalbuminuria and cIMT. Systolic blood 
pressure, microalbuminuria and cIMT had a positive correlation with osteopontin in people with diabetes. 
Stepwise multiple regression analysis showed that osteopontin had a significant correlation with cIMT. Receiver 
operating characteristic (ROC) curve showed that the cut off value of Osteopontin for detection of cIMT was > 60 
with a specificity of 100% and sensitivity 80.5%, while that of albumin/creatinine ratio was > 64 with a specificity of 
66.7 and sensitivity of 92.3. 
CONCLUSION: Osteopontin is higher in type 1 diabetics and is useful for early detection of diabetic 
microvascular and macrovascular complication. 
 
 
 
Introduction 
 
Osteopontin (OPN) is an adhesive molecule, 
rich in phosphorylated sialic acid and is a way 
between cells and minerals [1]. It increases in 
autoimmune diseases and chronic inflammation and is 
important for cytokine production in macrophages, 
dendritic cells, and T-cells [2]. It has a role in the 
occurrence of adipose tissue inflammation and insulin 
resistance [3]. It increases in aortic atherosclerotic 
plaques and other cardiovascular diseases [4]. OPN is 
useful for early detection of coronary calcification [5], 
diabetic retinopathy [6] and nephropathy [7] in type 2 
diabetes (T2DM). 
cIMT and aIMT is an easy, useful, non-
invasive method for early diagnosis of subclinical 
atherosclerosis in type 1 diabetic patients [8], [9]. 
From our knowledge, a very little publication was done 
for estimation of the relationship of OPN with a 
diabetic complication in adolescent type 1 diabetes. 
We aimed to assess the serum level of OPN in 
adolescent type 1 diabetes and to detect the 
association between OPN and diabetic complication 
(micro and macrovascular). 
 
 
Patients and Methods 
 
Seventy adolescent type 1 diabetics with 
duration of diabetes more than 5 years and 60 healthy 
volunteers from the endocrine clinic, Medical Center 
of Excellence, National Research Centre were 
enrolled in this cross-sectional study after taking 
approval from the ethical committee of the National 
Research Centre and a written consent from Patients 
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or their parents and healthy volunteers. Patients 
presented with any cardiac or vascular disease, 
hypertension, familial hyperlipidemia, receiving other 
medication rather than insulin were excluded from the 
study. 
A detailed history was taken; the general and 
local examination was done for all diabetics and 
controls. Anthropometric assessment including 
weight, height, midarm circumference, waist 
circumference and hip circumference were done. 
Calculation of body mass index (kg/height (m
2
), 
waist/hip ratio and waist/height ratio were done. Blood 
pressure was measured 3 times after 5-time rest in 
the sitting position by mercury sphygmomanometer. 
Venous blood samples were obtained from each 
subject in a sterile EDTA vacutainer tube for 
measuring glycated haemoglobin (HbA1c). It was 
measured using The NycoCard READER II (Alere 
Technologies AS, Kjelsåsveien 161, P.O. Box 6863 
Rodeløkka, NO-0504 Oslo, Norway). Glycated 
haemoglobin (HbA1c) was done every 3 months, and 
the mean value was calculated per year. 
A 2
nd
-morning urine sample was taken for 
diagnosis of microalbuminuria by measuring 
albumin/creatinine ratio. Microalbuminuria was 
diagnosed if the albumin/creatinine ratio was 30-299 
µg/g creatinine (measured by an immuno-
nephelometric method ) in 2 out of 3 samples ( 6 
months period) done every 2 months. Fasting venous 
blood (12 hr) for determination of lipid profile was 
done [10]. LDL-c (by Friedewald equation) and Tg (in 
a Techno Con AutoAnalyzer II, Tarrytown, NY, USA) 
were calculated. Serum OPN and OxLDL 
determination by ELISA kit (PELO-BIOTECH GmbH, 
Germany) were also done. 
 
Carotid intimal medial thickness cIMT 
Carotid Doppler was done by ultrasound 
General Electric: Vivid 7 Pro, GE Vingmed ultrasound 
AS-Nl90, Horton-Norway, 7.5 – 10 MHz linear-array 
transducer. Doppler was done in the supine position 
with an extended neck and turned head 45° to 
contralateral side [11]. The average of 3 
measurements each side was taken for calculation of 
cIMT [12], [13]. 
 
Aortic intimal medial thickness aIMT 
Abdominal aorta till aortic bifurcation was 
assessed by using 7.5 MHz pediatric phased array 
transducer. Aortic intimal medial thickness was 
measured by 10 MHz linear array transducer [14], 
[15]. The average of 3 measurements was taken to 
calculate the aIMT. 
 
Renal Doppler 
Renal colour duplex ultrasound scans using 
3-6 MHz convex array transducer (Toshiba, Xario 
ultrasound machine). Patients were scanned in the 
supine position. The transducer was placed in a 
longitudinal position just to the Lt. of the midline, 
recording colour flow and Doppler spectrum from the 
abdominal aorta where peak systolic velocity of the 
abdominal aorta was recorded. Then, the transducer 
was placed in transverse position just distal to the 
origin of superior mesenteric artery, to achieve 
transverse view of the aorta at the origins of both 
renal arteries where peak systolic velocity of both 
renal arteries was recorded, and renal artery stenosis 
was ruled out in all patients by tracing and examining 
different segments of both renal arteries from origin to 
renal hilum. Then, resistivity indices were recorded in 
the segmental, interlobar and arcuate arteries, on both 
sides [16], [17]. 
 
Statistical Analysis 
Statistical analysis was conducted using 
Statistical Package for Social Science (SPSS) 
program version 20 (Chicago, Illinois, USA) t-tests for 
independent variables was done. Pearson's 
correlation, followed by stepwise multiple regression 
analysis, was done. Receiver operating characteristic 
curve (ROC curve) was also done to detect sensitivity 
and specificity of OPN about cIMT and 
albumin/creatinine ratio. 
 
 
Results 
 
Diabetic patients had higher urinary albumin/ 
creatinine ratio, lipid profile (total cholesterol, Tg, LDL-
c), OxLDL, osteopontin, cIMT and aIMT (Table 1). 
Table 1: Comparison between demographics, laboratory data, 
anthropometric and image study of diabetic patients and 
controls 
Variables 
Patients 
N = 70 
Controls 
N = 60 P-value 
Mean SD Mean SD 
Age   of diabetics (yrs) 17.99 2.59 17.50 2.67 0.6 
Systolic blood pressure (mmHg) 118.45 13.33 123.75 10.61 0.30 
Diastolic blood pressure (mmHg) 76.55 10.06 80.00 10.69 0.40 
Midarm circumfrence (mm) 75.14 379.53 25.79 4.41 0.30 
Body mass index (kg/m
2
) 24.44 3.89 21.86 6.47 0.30 
Waist/hip ratio 0.88 0.08 0.88 0.07 0.90 
Waist/height ratio 0.51 0.07 0.48 0.10 0.40 
Albumin/creatinine ratio (µg/g 
creatinine) 
71.94 73.49 11.27 4.28 0.0001 
Total cholesterol (mg/dl) 194.86 63.65 159.94 22.20 0.0001 
Triglyceride (mg/dl) 106.59 53.12 88.21 30.37 0.03 
HDL-c (mg/dl) 49.31 16.35 48.78 10.01 0.40 
LDL-c (mg/dl_) 116.49 39.10 100.74 28.60 0.03 
OXLDL (mg/dl) 4.33 1.42 2.66 1.37 0.0001 
Osteopontin (mg/ml) 75.12 20.90 18.71 3.17 0.0001 
Carotid intimal medial thickness 
(mm) 
0.52 0.06 0.41 0.03 0.0001 
Aortic intimal medial thickness 
(mm) 
0.72 0.11 0.46 0.04 0.0001 
Resistivity index 0.67 0.04 0.65 0.05 0.30 
LDL: Low-density lipoprotein; HDL: high-density lipoprotein; OxLDL: Oxidized low-density 
lipoprotein. 
 
Diabetic patients with higher urinary 
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albumin/creatinine ratio and cIMT had a higher level of 
serum osteopontin (Table 2). 
Table 2: Comparison between osteopontin about 
microalbuminuria and to a carotid intimal medial thickness in 
type 1 diabetic patients 
Osteopontin 
(mg/ml) 
Negative microalbuminuria Positive microalbuminuria P-value 
Mean SD Mean SD 
0.01 
63.20 16.44 83.38 23.48 
Osteopontin 
(mg/ml) 
Negative cIMT Positive cIMT 
 
Mean SD Mean SD 
0.0001 
53.25 7.23 77.20 20.55 
cIMT:  carotid intimal medial thickness. 
 
Osteopontin had a relationship with 
albumin/creatinine ratio, systolic blood pressure and 
cIMT (Table 3). 
Table 3: Correlation between Osteopontin with demographics, 
laboratory data, anthropometric data and image study of 
diabetic patients 
Variables 
Osteopontin 
r P-value 
Demographic data: 
  
Age of diabetic patients (yrs) 0.10 0.44 
Duration of diabetes (yrs) 0.09 0.52 
Onset of disease (yrs) 0.22 0.10 
Insulin dose (u/kg) 0.08 0.55 
Blood pressure: 
  
Systolic blood pressure (mmHg) 0.28 0.03 
Diastolic blood pressure (mmHg) 0.01 0.92 
Anthropometric data: 
  
Midarm circumference (mm) 0.07 0.62 
Body mass index (kg/m2) 0.03 0.85 
Waist/ hip ratio 0.10 0.45 
Waist/height ratio 0.12 0.40 
Laboratory data: 
  
HbA1c (%) 0.19 0.16 
Urinary albumin/ creatinine ratio (µg/g 
creatinine) 
0.48 0.0001 
Total cholesterol (mg/dl) 0.04 0.76 
Triglyceride (mg/dl) 0.17 0.25 
HDL-c (mg/dl) 0.04 0.80 
LDL-c (mg/dl) 0.06 0.70 
OxLDL (mg/dl) 0.01 0.92 
Image study: 
  
carotid intimal medial thickness(mm) 0.64 0.0001 
Aortic intimal medial thickness (mm) 0.1 0.6 
Resistivity index 0.15 0.26 
HbA1c: glycosylated haemoglobin; LDL: Low-density lipoprotein; HDL: high-density 
lipoprotein; OxLDL: oxidised low-density lipoprotein. 
 
Stepwise multiple regression analysis of 
osteopontin as a dependent factor with demographic, 
anthropometric, laboratory data and image studies as 
an independent variable of diabetic patients revealed 
that osteopontin had a relationship with cIMT (Table 
4). 
Table 4: Stepwise multiple regression analysis of osteopontin 
about demographics, anthropometric data, laboratory data and 
image study in type 1 diabetic patients 
 
Unstandardized coefficent Standardized coefficent  
B SE Beta t P-value 
(Constant) -76.75 42.13 
 
-1.82 0.09 
cIMT (mm) 290.23 76.43 0.67 3.80 0.0001 
Dependent variables are osteopontin; cIMT: carotid intimal medial thickness. 
 
ROC curve of osteopontin demonstrate that 
the area under the curve (AUC) of cIMT was 0.9 with 
cut off value > 60 and high specificity and sensitivity 
(100, 80.5% respectively), on the other hand, AUC of 
urinary albumin/creatinine ratio was 0.8 with cut off 
value > 64, specificity and sensitivity ( 66.7 and 92.3 
respectively) (Table 5). 
Table 5: ROC curve of osteopontin about carotid intimal medial 
thickness and albumin/ creatinine ratio in type 1 diabetic 
patients 
Variables Cut off AUC SE 95%CI Sensitivity Specificity +LR -LR 
cIMT > 60 0.9 0.05 0.8 -1.0 81.5 100 0.2 100 
Albumin/creatin
ine ratio (µg/g 
creatinine) 
> 64 0.8 0.1 0.7 – 0.9 92.3 66.7 2.8 0.1 
 
 
 
Discussion 
 
In the current study, diabetic patients had 
higher albumin/creatinine ratio, lipid profile 
(cholesterol, Tg, LDL-c), OxLDL and aIMT were 
higher than cIMT which is comparable with [15], [18] 
who revealed that dyslipidemia is a risk factor of 
cardiovascular disease. Several previous studies 
revealed that cIMT and aIMT are increased in type 1 
diabetic patients indicating the early occurrence of 
subclinical atherosclerosis [19], [20]. 
In our study, all diabetic patients had higher 
OPN, and it is particularly higher in those with a 
diabetic complication in the form of diabetic 
nephropathy (positive microalbuminuria) or 
atherosclerosis (in the form of increased cIMT) which 
is comparable with the previous study [19]. 
Gordin et al., [21] demonstrated that adult 
type 1 diabetic patient with diabetic nephropathy had 
higher OPN and in follow up study patients who had 
higher baseline OPN level develop diabetic 
nephropathy (microalbuminuria or macroalbuminuria), 
cardiovascular or retinal disease later on. 
OPN had a relationship with systolic blood 
pressure, albumin/creatinine ratio and cIMT in our 
diabetic patients and no relation was found with 
glycemic control and stepwise multiple regression 
analysis revealed that the most important factor 
related to OPN is the cIMT. 
On the contrary, Abo El-Asrar et al., [19], 
reported that uncontrolled diabetes, microalbuminuria 
is associated with high OPN level. Also, a previous 
study revealed that high serum level of OPN is 
associated with long duration of diabetes, increase in 
waist/ hip ratio, high systolic blood pressure, 
microalbuminuria and increase high sensitive CRP (hs 
CRP) level and no relation was found with glycemic 
control (HbA1c) [21]. 
ROC curve of OPN in our study was done to 
estimate the cut off level at which we can early 
predicate patients with complication (cIMT and 
microalbuminuria). The area under the curve (AUC) of 
cIMT and microalbuminuria were 0.9 and 0.8 
respectively with cut off value > 60 and high specificity 
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and sensitivity (100, 80.5% respectively) for cIMT and 
cut off value > 64, specificity and sensitivity (66.7 and 
92.3 respectively) for urinary albumin/creatinine ratio. 
Our study is comparable with Abo EL Asrar et al., [19] 
study which found that 90 is a cut-off value of OPN for 
detection of microvascular complications with a 
sensitivity and specificity of 81.7, 95.8% respectively 
and AUC is 0.8. 
Yan et al., [22] revealed that OPN is 
associated with the development and degree of 
nephropathy and coronary affection in diabetic 
patients and can be used as a predictor of diabetic 
vasculopathy while Berezin and Kremzer [5] found 
that OPN can be used in coronary heart disease type 
2 diabetic patients as an early marker of coronary 
artery calcification. 
In conclusion, type 1 diabetic patients had 
subclinical atherosclerosis that can be diagnosed 
easily by non-invasive and an easy method cIMT and 
aIMT. OPN is increased in adolescent type 1 diabetic 
patients and can be used as an early marker for the 
diagnosis of diabetic nephropathy and subclinical 
atherosclerosis. 
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